Pharmesis International Ltd. (SGX:BFK)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.4350
-0.1450 (-25.00%)
At close: May 13, 2025, 5:00 PM SGT
262.50%
Market Cap 18.39M
Revenue (ttm) 12.65M
Net Income (ttm) 1.55M
Shares Out 31.70M
EPS (ttm) 0.05
PE Ratio 11.19
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,000
Average Volume 50
Open 0.4300
Previous Close 0.5800
Day's Range 0.4300 - 0.4350
52-Week Range 0.0650 - 0.7000
Beta -0.78
RSI 53.74
Earnings Date May 6, 2025

About Pharmesis International

Pharmesis International Ltd., an investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China. The company provides prescribed products and over-the-counter drugs. It offers western medicine products under the Kinna brand, including Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Compound Procaine hydrochloride to treat arterioscler... [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 1,096
Stock Exchange Singapore Exchange
Ticker Symbol BFK
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.